In vivo confocal microscopy analysis successful in detecting OSSN characteristics

Article

Using in vivo microscopy analysis is a safe and effective diagnostic tool in detecting ocular surface squamous neoplasia (OSSN) characteristics

Using in vivo microscopy analysis is a safe and effective diagnostic tool in detecting ocular surface squamous neoplasia (OSSN) characteristics, claims a study in the journal Eye.

Dr Y Xu et al., Department of Ophthalmology, Peking University Eye Center, Peking University Third Hospital, Beijing, China, conducted a case series on five patients with OSSN. All characteristics were identified by in vivo confocal microscopy before surgery.

Structure and cellular features of OSSN were analysed with anterior-segment optical coherence tomography (AS-OCT) and confirmed by histopathological biopsy.

The anterior segment photography revealed tumours with red gelatinous surfaces with vascular dilation of the ocular surface and corneal epithelium. In three cases the AS-OCT found only tumours in the corneal epithelium, but the Bowman's layer and anterior stroma were invaded in two of the cases.

In three patients in vivo confocal microscopy revealed cellular anisocystosis and enlarged nuclei with a high nuclear to cytoplasmic ratio. Characteristics identified by histopathological biopsy were similar to the results identified by in vivo confocal microscopy in all patients.

Overall, the procedure is a safe, relatively non-invasive and effective tool in identifying OSSN characteristics. It is a valuable tool for managing OSSN patients.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.